Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspectiveDelea, T.; El-Ouagari, K.; Karnon, J.; Sofrygin, O.
2008Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspectiveKarnon, J.; Delea, T.; Barghout, V.
2007Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancerOuagari, K.; Karnon, J.; Delea, T.; Talbot, W.; Brandman, J.
2006Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancerDelea, T.; Karnon, J.; Smith, R.; Johnston, S.; Brandman, J.; Sung, J.; Goss, P.
2003A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patientsKarnon, J.; Jones, T.
2011Cost-benefit analysis of endocrine therapy in the adjuvant setting for postmenopausal patients with hormone receptor-positive breast cancer, based on survival data and future prices for generic drugs in the context of the German health care systemLux, M.; Reichelt, C.; Karnon, J.; Tanzer, T.; Radosavac, D.; Fasching, P.; Beckmann, M.; Thiel, F.
2006Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: The UK perspectiveKarnon, J.; Delea, T.; Johnston, S.; Smith, R.; Brandman, J.; Sung, J.; Goss, P.